Federal Government to Send Millions of COVID-19 Tests to Nursing Homes
By Jim Crumly – Jul 16, 2020 at 3:04PM
NYSE: BDX
Becton, Dickinson And
Distribution of rapid point-of-care diagnostic instruments from Quidel and Becton, Dickinson will begin next week.
The U.S. Department of Health and Human Services (HHS) announced a large-scale buy of diagnostic instruments and COVID-19 tests that it will distribute to the nation's 15,400 nursing homes in coming months. The agency will begin to distribute the equipment and tests next week to 2,000 nursing homes ranked by the Centers for Medicare and Medicaid Services for being at highest risk for community spread of COVID-19.
The test instruments that HHS is distributing are the Sofia 2 from Quidel (QDEL) and BD Veritor Plus from Becton, Dickinson (BDX 0.84%). The instruments use immunoassay tests that detect SARS-CoV-2 antigens in samples from nasal swabs in 15 minutes. Both systems have been granted Emergency Use Authorization by the U.S. Food and Drug Administration.
HHS plans to ship the units and about 400 tests to every nursing home in the country. After that, facilities can order additional tests for under $25 each. The government says that each nursing home needs the capability to screen residents and to test staff at least weekly. By September, HHS hopes to have 15 million to 20 million tests available each month, but the companies will likely not have the production capacity to meet the full demand for the tests and supplies until October.
Jim Crumly owns shares of Quidel. The Motley Fool recommends Becton, Dickinson and Quidel. The Motley Fool has a disclosure policy.
QDEL
3 Top Dividend Kings to Buy for the Long Haul
3 Stocks Warren Buffett Bought in the Last Big Recession -- Are They Buys Now?
Buy These 2 Rock-Solid Stocks Instead of Exiting the Market
Scared of a Bear Market? Buy This Rock-Solid Stock Now